Literature DB >> 1676991

Adrenergic mechanism in circadian elevation of intraocular pressure in rabbits.

J H Liu1, A C Dacus, S P Bartels.   

Abstract

Stimulation of the ocular sympathetic nerves is essential for the circadian elevation of intraocular pressure (IOP) in rabbits. Adrenergic mechanisms that participate in this elevation of IOP around the onset of darkness were investigated using selective adrenergic agents. Unilateral topical administration of 0.0001-0.1% prazosin, an alpha-1-adrenergic antagonist, at the onset of darkness caused a dose-dependent reduction of IOP elevation. After treatment with 0.1% prazosin, the concentration of norepinephrine (NE) in aqueous humor was not changed, but the aqueous humor protein concentration was reduced. The increase of aqueous flow, determined by fluorophotometry, after the onset of darkness was not affected by 0.1% prazosin treatment. Treatment of rauwolscine, an alpha-2-adrenergic antagonist, or timolol, a beta-adrenergic antagonist, was ineffective in reducing the circadian elevation of IOP. Apraclonidine, an alpha-2-adrenergic agonist, with concentrations of 0.0001-1% caused a dose-dependent reduction of IOP elevation. Treatment with 1% apraclonidine caused a 70% reduction of aqueous humor NE, a significant attenuation of the increase of aqueous flow, and no change of aqueous humor protein concentration. These results suggest that both an increase of aqueous outflow resistance (by alpha-1-adrenergic receptors) and an increase of aqueous flow (not exclusively by beta-adrenergic receptors) contribute to the circadian elevation of IOP. Prejunctional alpha-2-adrenergic receptors may serve as an autoregulating mechanism to limit the excess release of NE and hypertensive spike in IOP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676991

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy.

Authors:  Consuelo Pérez-Rico; Esperanza Gutiérrez-Díaz; Enrique Mencía-Gutiérrez; María Josefa Díaz-de-Atauri; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-25       Impact factor: 3.117

2.  Elevation of intraocular pressure in glaucoma patients after automated visual field testing.

Authors:  Nina Ni; James C Tsai; M Bruce Shields; Nils A Loewen
Journal:  J Glaucoma       Date:  2012-12       Impact factor: 2.503

3.  The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

Authors:  Kelly J Sigle; Gabriel Camaño-Garcia; Alicia L Carriquiry; Daniel M Betts; Markus H Kuehn; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

4.  Direct effect of light on 24-h variation of aqueous humor protein concentration in Sprague-Dawley rats.

Authors:  Chad M Valderrama; Ruixia Li; John H K Liu
Journal:  Exp Eye Res       Date:  2008-09-10       Impact factor: 3.467

5.  Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles.

Authors:  Noriaki Nagai; Sakie Yamaoka; Yuya Fukuoka; Miyu Ishii; Hiroko Otake; Kazutaka Kanai; Norio Okamoto; Yoshikazu Shimomura
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

Review 6.  Ocular Clocks: Adapting Mechanisms for Eye Functions and Health.

Authors:  Marie-Paule Felder-Schmittbuhl; Ethan D Buhr; Ouria Dkhissi-Benyahya; David Hicks; Stuart N Peirson; Christophe P Ribelayga; Cristina Sandu; Rainer Spessert; Gianluca Tosini
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.